Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2030008 | 1.00 | MYC (0.56) | MYCKDM4EKMT2AGFERRXFP1 | |
| SCHEMBL31597491 | 1.00 | MYC (0.56) | MYCKDM4EKMT2AGFERRXFP1 | |
| SCHEMBL11097889 | 0.88 | MYC (0.47) | MYCKDM4EKMT2AGFERRXFP1 | |
| SCHEMBL8980390 | 0.87 | ALDH1A1 (0.53) | MYCKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL973116 | 0.86 | TDP1 (0.54) | MYCKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL10625157 | 0.85 | KMT2A (0.57) | KDM4EKMT2AGFERRXFP1TDP1 | |
| SCHEMBL10580566 | 0.84 | KMT2A (0.55) | KDM4EKMT2AGFERRXFP1TDP1 | |
| SCHEMBL2500845 | 0.83 | MYC (0.61) | MYCKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL7458280 | 0.83 | SMN1; SMN2 (0.64) | KDM4EKMT2ATDP1MEN1MAPT | |
| SCHEMBL7453002 | 0.83 | HDAC1 (0.51) | KDM4ETDP1ALDH1A1GLAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343556-A | Bio-based compound modified cracking carbon black and application thereof in tire preparation | 中策橡胶集团股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117247608-A | Tire pad rubber composition containing bio-based modified cracking carbon black, mixing method and tire | 中策橡胶集团股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117247639-A | Tire inner liner rubber composition containing bio-based modified cracking carbon black, mixing method and tire | 中策橡胶集团股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-114057917-A | Post-treatment ashless dispersant and preparation method thereof | 中国石油天然气股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-111925494-B | High-viscosity waterborne polyurethane and preparation method thereof | 温州大学新材料与产业技术研究院 | 2021-12-14 | — | — | CN | claimed |
| CN-111925494-A | High-viscosity waterborne polyurethane and preparation method thereof | 温州大学新材料与产业技术研究院 | 2020-11-13 | — | — | CN | claimed |
| CN-107602809-B | High-solid-content aqueous polyurethane dispersion liquid based on aminocarboxylate and sulfamate simultaneously | 温州大学 | 2020-05-22 | — | — | CN | claimed |
| CN-107602809-A | High-solid content water-based polyurethane dispersion liquid a kind of while based on aminocarboxylate and sulfamate | 温州大学 | 2018-01-19 | — | — | CN | claimed |
| EP-2109465-A2 | POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME | Kempharm, Inc. (US) | 2009-10-21 | — | — | EP | claimed |
| US-20090239949-A1 | Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same | SHIRE LLC | 2009-09-24 | — | — | US | claimed |
| WO-2008098151-A2 | POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME | KEMPHARM, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| JP-9279051-A | — | — | None | — | — | JP | disclosed |
| US-12599578-B2 | Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof | Ensysce Biosciences Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20250361205-A1 | ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF | ENSYSCE BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-12384744-B2 | Enzyme-cleavable methadone prodrugs and methods of use thereof | Ensysce Biosciences Inc. (US) | 2025-08-12 | — | — | US | disclosed |
| US-3989692-A | PHTHALOCYANINE DYES, WOOL, SILK, POLYAMIDES, CELLULOSE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3988310-A | FIBER-REACTIVE DYES; CELLULOSE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-26 | — | — | US | disclosed |
| US-3971741-A | DISPERSION PIGMENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3971738-A | Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239949-A1 | Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same | SLC6A2, SLC6A3, SLC18A2 | MYC 1691/4885KDM4E 2162/4885KMT2A 1364/4885 |
| US-12599578-B2 | Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof | OPRK1, OPRL1, OPRM1 | MYC 4491/4885KDM4E 1350/4885KMT2A 1764/4885 |
| US-12384744-B2 | Enzyme-cleavable methadone prodrugs and methods of use thereof | CES2, ACHE, COMT | MYC 3802/4885KDM4E 1056/4885KMT2A 1230/4885 |
| US-20250361205-A1 | ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF | CES2, ACHE, COMT | MYC 3802/4885KDM4E 1056/4885KMT2A 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.